VALERIE NELSON: Open Payments
NPI 1386242162 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 36 payments from 16 companies in 2025. Trend: 2023 $1,214 · 2024 $546 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $196 |
| Syndax Pharmaceuticals, Inc. | 3 | $173 |
| Legend Biotech USA Inc. | 6 | $156 |
| JAZZ PHARMACEUTICALS INC. | 4 | $102 |
| SANOFI-AVENTIS U.S. LLC | 2 | $74 |
| Genmab U.S., Inc. | 2 | $59 |
| PFIZER INC. | 2 | $50 |
| Astellas Pharma US Inc | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| ABBVIE INC. | 2 | $44 |
Products named: CARVYKTI, RYBREVANT, REVUFORJ, EPKINLY, REZUROCK, DEFITELIO, Xospata, RYLAZE.
Industry payments across AZ — which companies pay providers there.
